Low Gradient Aortic Stenosis: Is Invasive Assessment Viable?

There is an important group of patients presenting low flow, low-gradient severe aortic stenosis (defined as mean gradient <40 mmHg). This is why we do dobutamine stress echocardiogram (DSE), to confirm whether we are dealing with truly severe aortic stenosis. However, it might not be well tolerated and a CT angiography will be done to assess valve calcification. 

The study looked at 28 patients presenting mean low-gradient < 40 mmHg and aortic valve area <1 cm2. It excluded patients presenting atrial fibrillation, DSE contraindication and left ventricular outflow tract obstruction. A premature ventricular contraction was induced by intentional catheter contact with the myocardium within the left ventricle. 

Mean age was 77 and 19 were women. 8 patients presented diabetes, 16 hypertension, 5 COPD, 17 coronary artery disease, and 9 prior myocardial revascularization surgery (CABG).

Core Lab analysis showed systolic volume rate <35 ml/m2 in 15 patients and CT angiography showed severe calcification in other 15. 

DSE showed baseline mean gradient increase from 25±7 mmHg to 36±11 mmHg. Also we observed an increase in postextrasystolic potentiation from 25±7 mmHg to 32.10 mmHg, representing an increase of 24±11%.

Read also: BASILICA: a Complex Strategy, Yet Safe.

A >20% increase in postextrasystolic potentiation resulted in 100% sensitivity, 77% specificity, 83% positive predictive value and 100% negative predictive value for severe aortic stenosis diagnosis. 

CT angio also showed significant correlation between postextrasystolic potentiation and projected aortic valve area and aortic valve calcification density (R=−0.64, P=0.0003; R=0.057, P=0.014, respectively).

Conclusion

In patients with low gradient aortic stenosis catheter-induced premature ventricular contractions during cardiac catheterization causing ≥20% PESP has a 100% sensitivity for severe aortic valve stenosis. Further analysis of larger populations is required to validate this 20% cutoff value. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Catheter-Induced Postextrasystolic Potentiation in the Assessment of Severity of Low-Gradient Aortic Valve Stenosis.

Reference: Payam Dehghani, et al. Circ Cardiovasc Interv. 2023;16:e012892. DOI: 10.1161/CIRCINTERVENTIONS.123.012892.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...